Method optimisation for peptide profiling of microdissected breast carcinoma tissue by matrix-assisted laser desorption/ionisation-time of flight and matrix-assisted laser desorption/ionisation-time of flight/time of flight-mass spectrometry - PubMed (original) (raw)
Method optimisation for peptide profiling of microdissected breast carcinoma tissue by matrix-assisted laser desorption/ionisation-time of flight and matrix-assisted laser desorption/ionisation-time of flight/time of flight-mass spectrometry
Arzu Umar et al. Proteomics. 2005 Jul.
Abstract
Appropriate methods for the analysis of microdissected solid tumour tissues by matrix-assisted laser desorption/ionisation-time of flight-mass spectrometry (MALDI-TOF MS) are not yet well established. Optimisation of sample preparation was performed first on undissected tissue slices, representing approximately 200 000 cells, which were solubilised either in urea containing buffer, trifluoroethanol/NH4HCO3, 0.1% sodium dodecyl sulphate (SDS) or in 0.1% RapiGest solution, then trypsin digested and analysed by MALDI-TOF MS. Solubilisation in 0.1% SDS resulted in detection of the highest number of sample specific peak signals. Interestingly, there was little overlap in detectable peaks using the different buffers, implying that they can be used complementarily to each other. Additionally, we fractionated tryptic digests on a monolithic high-performance liquid chromatography column. Fractionation of tryptic digest from whole tissue sections resulted in a four-fold increase in the total number of peaks detected. To prove this principle, we used 0.1% SDS to generate peptide patterns from 2000 microdissected tumour and stromal cells from five different breast carcinoma tumours. The tumour and stroma specific peaks could be detected upon comparison of the peptide profiles. Identification of differentially expressed peaks by MALDI-TOF/TOF MS was performed on fractionated tryptic digests derived from a whole tissue slice. In conclusion, we describe a method that is suitable for direct peptide profiling on small amounts of microdissected cells obtained from breast cancer tissues.
Similar articles
- Clinical proteomics in breast cancer: a review.
Gast MC, Schellens JH, Beijnen JH. Gast MC, et al. Breast Cancer Res Treat. 2009 Jul;116(1):17-29. doi: 10.1007/s10549-008-0263-3. Epub 2008 Dec 11. Breast Cancer Res Treat. 2009. PMID: 19082706 Review. - Direct profiling and imaging of peptides and proteins from mammalian cells and tissue sections by mass spectrometry.
Chaurand P, Caprioli RM. Chaurand P, et al. Electrophoresis. 2002 Sep;23(18):3125-35. doi: 10.1002/1522-2683(200209)23:18<3125::AID-ELPS3125>3.0.CO;2-#. Electrophoresis. 2002. PMID: 12298084 Review.
Cited by
- High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
Riaz M, Sieuwerts AM, Look MP, Timmermans MA, Smid M, Foekens JA, Martens JW. Riaz M, et al. Breast Cancer Res. 2012 Sep 11;14(5):R123. doi: 10.1186/bcr3317. Breast Cancer Res. 2012. PMID: 22967435 Free PMC article. - Optimization of protein solubilization for the analysis of the CD14 human monocyte membrane proteome using LC-MS/MS.
Ye X, Johann DJ Jr, Hakami RM, Xiao Z, Meng Z, Ulrich RG, Issaq HJ, Veenstra TD, Blonder J. Ye X, et al. J Proteomics. 2009 Nov 2;73(1):112-22. doi: 10.1016/j.jprot.2009.08.008. Epub 2009 Aug 24. J Proteomics. 2009. PMID: 19709643 Free PMC article. - An in-solution ultrasonication-assisted digestion method for improved extracellular matrix proteome coverage.
Hansen KC, Kiemele L, Maller O, O'Brien J, Shankar A, Fornetti J, Schedin P. Hansen KC, et al. Mol Cell Proteomics. 2009 Jul;8(7):1648-57. doi: 10.1074/mcp.M900039-MCP200. Epub 2009 Apr 7. Mol Cell Proteomics. 2009. PMID: 19351662 Free PMC article. - Transforming Diagnosis and Therapeutics Using Cancer Genomics.
Mehmood S, Aslam S, Dilshad E, Ismail H, Khan AN. Mehmood S, et al. Cancer Treat Res. 2023;185:15-47. doi: 10.1007/978-3-031-27156-4_2. Cancer Treat Res. 2023. PMID: 37306902 - Proteomic studies in breast cancer (Review).
Qin XJ, Ling BX. Qin XJ, et al. Oncol Lett. 2012 Apr 1;3(4):735-743. doi: 10.3892/ol.2012.573. Epub 2012 Jan 18. Oncol Lett. 2012. PMID: 22740985 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous